Report of foreign issuer [Rules 13a-16 and 15d-16]

INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.26.1
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2024 $ 0 $ 808,974 $ (730,045) $ 78,929
Beginning balance (Shares) at Dec. 31, 2024 169,397,030      
Issuance of common shares and warrants, net of issuance costs $ 0 37,289 0 37,289
Issuance of common shares and warrants, net of issuance costs (Shares) 28,776,978      
Exercise of shares options $ 0 102 0 102
Exercise of shares options (Shares) 138,607      
Vesting of RSUs $ 0 0 0 0
Vesting of RSUs (Shares) 734,752      
Share-based compensation $ 0 4,087 0 4,087
Net Loss 0 0 (12,642) (12,642)
Ending balance at Mar. 31, 2025 $ 0 850,452 (742,687) 107,765
Ending balance (Shares) at Mar. 31, 2025 199,047,367      
Beginning balance at Dec. 31, 2025 $ 0 875,558 (797,840) 77,718
Beginning balance (Shares) at Dec. 31, 2025 214,090,980      
Issuance of ordinary shares, net of issuance costs $ 0 4,158 0 4,158
Issuance of ordinary shares, net of issuance costs (Shares) 6,163,432      
Exercise of shares options $ 0 18 0 18
Exercise of shares options (Shares) 31,607      
Vesting of RSUs $ 0 0 0 0
Vesting of RSUs (Shares) 1,079,315      
Share-based compensation $ 0 3,969 0 3,969
Net Loss 0 0 (26,199) (26,199)
Ending balance at Mar. 31, 2026 $ 0 $ 883,703 $ (824,039) $ 59,664
Ending balance (Shares) at Mar. 31, 2026 221,365,334